Triple Negative Breast Cancer Market: Evolving Landscape and Future Outlook by DelveInsight
Triple Negative Breast Cancer (TNBC) is a particularly aggressive subtype of breast cancer that lacks estrogen, progesterone, and human epidermal growth factor receptor 2 (HER2). The absence of these receptors means TNBC patients cannot benefit from hormonal or HER2-targeted therapies, complicating treatment strategies.   Support Research, Save Lives from Triple Negative Breast Cancer:...
0 Comments 0 Shares 64 Views 0 Reviews